Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Mute International aim to make electric scooters and bicycles immediately available for use through their technology driven usership programmes. The bike supply programs are tailored to individual and commercial needs without the constraints and costs of ownership whilst also making a difference to the environment.
days to go:
Expired
investment:
£749,660
Sunswap is a solar and battery-powered transport refrigeration company that keeps food, medicine, and vaccines cold whilst on the road. The company argues that diesel-powered Transport Refrigeration Units (TRUs) are expensive to operate and highly polluting. It proclaims that replacing a diesel TRU with a Sunswap TRU could be the equivalent of removing 31 cars from the road. Sunswap asserts that the TRU market would have a market worth £13.4 billion by 2030. The company aims to be a contender in this segment and claims that electric TRU sales will follow the electric vehicle adoption curve with a 60% Year-on-Year growth. Sunswap has successfully tested its working prototype's capability to meet the temperature requirements of -22°C. It is collaborating with six major UK supermarkets on product development, with aims to secure sales with them in 2021. The company will use the investment to grow its team, build the next generation product, and secure sales by the end of 2021.
days to go:
Expired
investment:
£535,000
nHouse supplies modular method eco-friendly homes and by building homes in controlled factory enviroments, each module is defect-free before being transported to the site for assembly, resulting in cost saving and increase customizability. Their homes boast energy efficiency with A rating at EPC, resulting in minimized energy costs for occupants and redice carbon emissions.
days to go:
Expired
investment:
£183,839
SHERPR is the ultimate door to door solution for transporting sports equipment, namely bikes, skis, snowboards and golf clubs. The company delivers premium packaging specifically designed to protect sports equipments in transit. The SHERPR business model taps into the growing leisure market with three core offerings: door to door transportation, bespoke logistic solutions for mass participation events, and a range of bike boxes. SHERPR has achieved impressive growth quarter on quarter and is currently looking to capitalize on the demands that it has created since its launch in 2017.
days to go:
Expired
investment:
£143,494
Six to Start are the co-creators of the popular fitness game 'Zombies, run!' and are now raising investment to grow this and to also build a new app called 'Virtual Races.' With over 3,000,000 downloads and peaks of 250k monthly active users, Zombie, Run! brings together audio storytelling and gameplay with real-world exercise. Virtual Races has already attracted over 15,000 entrants and generated over £600K+ in revenue.
days to go:
Expired
investment:
£249,970
Movebubble have created a platform that connects renters with properties. Movebubble is available as a mobile app making it easy to chat and schedule viewings on the go. Their aim is to make it easier and faster to find a home to rent.
days to go:
Expired
investment:
£833,051
Amchara Health specialises in bringing a better approach to creating a personalised health solution tailored to a person's needs and goals. Its aim is to educate and empower people about better health choices. This residential retreat brand is developing three health & wellness applications: HealthHub360, MyAmchara, and Amchara360. In the first 12 months, the company will aim to achieve more than 100,000 downloads of the Healthhub360 application. With the proceeds, Amchara will be marketing the MyAmchara app and rebrand it. Furthermore, there will be an international development of the application to cater to Canada, Australia, and the USA.
days to go:
Expired
investment:
£167,619
